Single Domain Antibody Platforms Market 2022
The global Single Domain Antibody Platforms Market is likely to jump the innovation gun by reaching US$ 22 Mn by the year 2022. The CAGR would be 10%. With mental health being the prerogative, there is telepsychiatry in place. It has been a proven fact that physical ailments would get cured speedily if the psyche is in place. With geographical barriers getting transcended, telepsychiatry would be an indispensable part of the healthcare vertical. This would be the fact about the healthcare vertical in the future.
Monoclonal antibodies are highly efficient as therapeutics against viral infections, immune diseases, and cancer. However, they are large in size and unable to access some epitopes, besides the production cost being high. Hence, single-domain antibodies (sdAbs) is an alternative for monoclonal due to larger number of accessible epitopes, smaller size, relatively low production costs, and potent inhibitors against immune and viral diseases. Currently, single-domain antibodies are being developed against a number of viruses, including influenza viruses, HIV, hepatitis C virus (HCV), enteric viruses, and respiratory syncytial virus (RSV).
Technological advancements in single-domain antibody platforms such as production of bispecific and multi-specific antibodies to target particular antigens during therapeutic developments are some other factors that will boost the growth of the single-domain antibody platforms market.
To remain ‘ahead’ of your competitors, request for free sample copy @ https://www.persistencemarketresearch.com/samples/28351
According to a latest report published by PMR, the global single-domain antibody platforms market is projected to be valued at US$ 22 Mn in 2020, and is expected to witness an impressive CAGR of around 10% during the forecast period (2020 – 2030).
Key Takeaways from Single-Domain Antibody Platforms Market Study
- The bispecific single-domain antibody segment under platform type is expected to contribute more than 30% of revenue share in the single-domain antibody platforms market.
- By application, therapeutic development accounted for the highest market share in 2019. Single-domain antibodies are highly effective in immune therapy, and antiviral therapy is anticipated to drive demand for single-domain antibody platforms.
- Developing countries such as India, China, and South Africa are projected to register positive growth over the coming years, due to increase in drug development activities in these regions.
- Leading players are focused on improving their service and established collaborations with research institutes and provide customized products.
- The COVID-19 outbreak has created a positive impact on the single-domain antibody platforms market, with increased demand for antibodies in the treatment against COVID-19.
“Rise in prevalence of infectious disease and demand for immunotherapy for preventive treatments will boost the global single-domain antibody platforms market,” says a PMR analyst.
Get a Customized Scope to Match Your Need Ask an Expert- https://www.persistencemarketresearch.com/request-customization/28351
Collaborations & Acquisitions – Key Strategies amongst Market Players
Leading players in the single-domain antibody platforms market are strengthening their product portfolios by launching new products.
- For instance, in July 2020, Creative Biolabs developed over 400 types of therapeutic antibodies that can be applied to the study on COVID-19 drugs.
- ProSci Incorporated announced the release of multiple single-domain antibodies against the human programmed death ligand 1 (PD-L1).
- In May, 2016, Antibody Design Labs offered a complete line of services for single-domain antibody development, including single-domain antibody phage libraries, immunization, and large-scale production of recombinant single-domain antibodies
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the single-domain antibody platforms market in its latest study, presenting historical demand assessment of 2015 – 2019 and projections for 2020 – 2030, on the basis of platform type (multi-specific single-domain antibody, bispecific single-domain antibody, multivalent single-domain antibody, and mono-specific single-domain antibody), animal source (camelids and sharks), application (diagnostic laboratories, therapeutic development, and research & development activities) and end user (diagnostic laboratories, clinical laboratories, academic and research institutes, and pharmaceutical and biotechnology companies), across seven key regions.
For in-depth competitive analysis, buy now @ https://www.persistencemarketresearch.com/checkout/28351
Key Questions Answered in the Single Domain Antibody Platforms Market Report
How is the Single Domain Antibody Platforms Market expected to grow over the projected period?
What direction is the Single Domain Antibody Platforms Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Single Domain Antibody Platforms Market in future?
What are the key market drivers in the Single Domain Antibody Platforms Market?
What are significant opportunities and improvement areas for Single Domain Antibody Platforms Market manufacturers?
What are the key developments and trends taking over the Single Domain Antibody Platforms Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Single Domain Antibody Platforms Market?
If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.
Related Reports:
Osteoporosis Drugs Market – Global osteoporosis drugs market is anticipated to grow from an estimated US$11,226.1 Mn in 2015 to account for US$14,786.7 Mn by 2022 at a CAGR of 4.0% with good revenue.
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com